Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.4715199658350734e-22,87.00765696784073,4373.925048620748,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.856015887255742e-20,0,0,67
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.8204560711147206e-13,inf,inf,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",3.003752517339289e-11,0,0,37
3,Oxidative phosphorylation WP623,6.70405376600893e-08,inf,inf,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF']",7.374459142609823e-06,0,0,21
4,Nonalcoholic fatty liver disease WP4396,4.903926314135693e-07,6.748908296943231,98.04854115025366,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRFS1', 'CYC1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",4.045739209161947e-05,0,0,33
5,Mitochondrial complex I assembly model OXPHOS system WP4324,3.5297039743939576e-06,inf,inf,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.0002329604623100012,0,0,16
6,Mitochondrial CIV Assembly WP4922,1.713695168559874e-05,inf,inf,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",0.0009425323427079307,0,0,14
7,Mitochondrial complex III assembly WP4921,0.004217705432902278,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1']",0.19883468469396454,0,0,7
8,Amino Acid metabolism WP3925,0.0092329112018128,inf,inf,"['LDHA', 'PKM', 'GOT1', 'GSS', 'ODC1', 'SRM']",0.3385400773998027,0,0,6
9,Glycolysis and Gluconeogenesis WP534,0.0092329112018128,inf,inf,"['LDHA', 'PKM', 'GOT1', 'PGAM1', 'ALDOC', 'PFKM']",0.3385400773998027,0,0,6
10,7q11.23 copy number variation syndrome WP4932,0.039324213454773244,7.126050420168068,23.05929224383981,"['ATP5MC2', 'EIF4H', 'ATP5MC3', 'GTF2IRD1', 'ATP5F1E', 'ATP5MC1']",0.9986840967066791,0,0,6
11,Pancreatic adenocarcinoma pathway WP4263,0.039324213454773244,7.126050420168068,23.05929224383981,"['TGFB1', 'CDKN2A', 'PRKCD', 'BAX', 'PLD1', 'GADD45G']",0.9986840967066791,0,0,6
12,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.044144155642176976,inf,inf,"['NDUFA13', 'HSP90AA1', 'RIPK2', 'AAMP']",0.9986840967066791,0,0,4
13,Pathways in clear cell renal cell carcinoma WP4018,0.07501301723725863,5.93006993006993,15.359436276270124,"['LDHA', 'PKM', 'TGFB1', 'ALDOC', 'PFKM']",0.9986840967066791,0,0,5
14,Cellular Proteostasis WP4918,0.09641546487706033,inf,inf,"['VBP1', 'PFDN5', 'PFDN6']",0.9986840967066791,0,0,3
15,Type 2 papillary renal cell carcinoma WP4241,0.09641546487706033,inf,inf,"['TGFB1', 'COL21A1', 'ELOB']",0.9986840967066791,0,0,3
16,Computational Model of Aerobic Glycolysis WP4629,0.09641546487706033,inf,inf,"['LDHA', 'PKM', 'PFKM']",0.9986840967066791,0,0,3
17,Glycolysis in senescence WP5049,0.09641546487706033,inf,inf,"['LDHA', 'PKM', 'ALDOC']",0.9986840967066791,0,0,3
18,Ferroptosis WP4313,0.0965016595358325,3.5588235294117645,8.32122364400674,"['MAP1LC3A', 'GPX4', 'GSS', 'VDAC3', 'SAT2', 'FTL']",0.9986840967066791,0,0,6
19,Fragile X Syndrome  WP4549,0.0965016595358325,3.5588235294117645,8.32122364400674,"['PRKAR1A', 'CDKN2A', 'PPP2R5B', 'SLC6A1', 'GABRD', 'SHANK1']",0.9986840967066791,0,0,6
20,Acute viral myocarditis WP4298,0.13993580885020726,4.737430167597766,9.31649500744863,"['ENDOG', 'TGFB1', 'CYCS', 'BAX']",0.9986840967066791,0,0,4
21,Base Excision Repair WP4752,0.13993580885020726,4.737430167597766,9.31649500744863,"['POLE4', 'NEIL2', 'APEX1', 'POLE2']",0.9986840967066791,0,0,4
22,Corticotropin-releasing hormone signaling pathway WP2355,0.13993580885020726,4.737430167597766,9.31649500744863,"['HSP90AA1', 'TGFB1', 'PRKCD', 'CRH']",0.9986840967066791,0,0,4
23,DNA IR-double strand breaks and cellular response via ATM WP3959,0.13993580885020726,4.737430167597766,9.31649500744863,"['DCLRE1C', 'KAT5', 'CDKN2A', 'BAX']",0.9986840967066791,0,0,4
24,Neural Crest Differentiation WP2064,0.13993580885020726,4.737430167597766,9.31649500744863,"['DLX5', 'LHX2', 'FGFR2', 'GFAP']",0.9986840967066791,0,0,4
25,Rett syndrome causing genes WP4312,0.13993580885020726,4.737430167597766,9.31649500744863,"['KCNJ10', 'IMPDH2', 'HAP1', 'GABRD']",0.9986840967066791,0,0,4
26,Proteasome Degradation WP183,0.17923382722266826,2.369747899159664,4.073748369518761,"['PSMD8', 'PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'PSMB10']",0.9986840967066791,0,0,6
27,DNA Repair Pathways Full Network WP4946,0.18898982919695972,2.07398316970547,3.4553847118275147,"['FANCI', 'POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'POLE2', 'APEX1']",0.9986840967066791,0,0,7
28,mRNA Processing WP411,0.18898982919695972,2.07398316970547,3.4553847118275147,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'SNRPE', 'SNU13', 'SRSF9']",0.9986840967066791,0,0,7
29,Amyotrophic lateral sclerosis (ALS) WP2447,0.21042235741635618,inf,inf,"['TOMM40', 'BAX']",0.9986840967066791,0,0,2
30,CAMKK2  Pathway WP4874,0.21042235741635618,inf,inf,"['FIS1', 'MAP1LC3A']",0.9986840967066791,0,0,2
31,Type II diabetes mellitus WP1584,0.21042235741635618,inf,inf,"['SURF1', 'PRKCD']",0.9986840967066791,0,0,2
32,Urea cycle and metabolism of amino groups WP497,0.21042235741635618,inf,inf,"['ODC1', 'SRM']",0.9986840967066791,0,0,2
33,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.21042235741635618,inf,inf,"['TGFB1', 'VIP']",0.9986840967066791,0,0,2
34,Cori Cycle WP1946,0.21042235741635618,inf,inf,"['LDHA', 'PGAM1']",0.9986840967066791,0,0,2
35,Dual hijack model of Vif in HIV infection WP3300,0.21042235741635618,inf,inf,"['ELOB', 'RUNX1']",0.9986840967066791,0,0,2
36,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.21042235741635618,inf,inf,"['H3F3B', 'H2AFZ']",0.9986840967066791,0,0,2
37,Gastric acid production WP2596,0.21042235741635618,inf,inf,"['CCK', 'VIP']",0.9986840967066791,0,0,2
38,Glutathione metabolism WP100,0.21042235741635618,inf,inf,"['GPX4', 'GSS']",0.9986840967066791,0,0,2
39,Hematopoietic Stem Cell Differentiation WP2849,0.21042235741635618,inf,inf,"['PIM1', 'RUNX1']",0.9986840967066791,0,0,2
40,Histone Modifications WP2369,0.21042235741635618,inf,inf,"['SET', 'H3F3B']",0.9986840967066791,0,0,2
41,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.21042235741635618,inf,inf,"['SFRP1', 'TGFB1']",0.9986840967066791,0,0,2
42,NO/cGMP/PKG mediated Neuroprotection WP4008,0.21042235741635618,inf,inf,"['PDE3A', 'CYCS']",0.9986840967066791,0,0,2
43,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.21042235741635618,inf,inf,"['EIF3I', 'EIF3D']",0.9986840967066791,0,0,2
44,Osteoclast Signaling WP12,0.21042235741635618,inf,inf,"['AIMP2', 'ATP6V1G1']",0.9986840967066791,0,0,2
45,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.21042235741635618,inf,inf,"['TGFB1', 'BAX']",0.9986840967066791,0,0,2
46,SARS-CoV-2 mitochondrial interactions WP5038,0.21042235741635618,inf,inf,"['NDUFB9', 'PHB']",0.9986840967066791,0,0,2
47,VEGFA-VEGFR2 Signaling Pathway WP3888,0.2359599213107808,1.2962382445141065,1.8718889813889854,"['HSP90AA1', 'SET', 'SSR4', 'TRPC3', 'PRKCD', 'RPL13A', 'RPL10A', 'RPL7', 'DNAJA1', 'SCUBE2', 'LDHA', 'RCN1', 'RPL18A', 'TMSB4X', 'DNAJB4', 'RPLP2', 'DNAJB9', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'CCT7', 'EIF3D', 'ARF6']",0.9986840967066791,0,0,24
48,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.25322933480458826,3.5481171548117154,4.873196061973448,"['MAP1LC3A', 'IGFBP5', 'PLD1']",0.9986840967066791,0,0,3
49,Glycosylation and related congenital defects WP4521,0.25322933480458826,3.5481171548117154,4.873196061973448,"['DPM3', 'MAGT1', 'MPDU1']",0.9986840967066791,0,0,3
50,Metabolic reprogramming in colon cancer WP4290,0.25322933480458826,3.5481171548117154,4.873196061973448,"['LDHA', 'PKM', 'PGAM1']",0.9986840967066791,0,0,3
51,Nanomaterial induced apoptosis WP2507,0.25322933480458826,3.5481171548117154,4.873196061973448,"['ENDOG', 'BAX', 'CYCS']",0.9986840967066791,0,0,3
52,Nucleotide metabolism WP404,0.25322933480458826,3.5481171548117154,4.873196061973448,"['NME2', 'OAZ1', 'SRM']",0.9986840967066791,0,0,3
53,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.25322933480458826,3.5481171548117154,4.873196061973448,"['HSP90AA1', 'CDKN2A', 'BAX']",0.9986840967066791,0,0,3
54,Prader-Willi and Angelman Syndrome WP3998,0.25322933480458826,3.5481171548117154,4.873196061973448,"['DLX5', 'CDKN2A', 'GABRD']",0.9986840967066791,0,0,3
55,Aryl Hydrocarbon Receptor Pathway WP2873,0.2697813682280821,2.3659217877094973,3.0996968039866757,"['HSP90AA1', 'TGFB1', 'AIP', 'BAX']",0.9986840967066791,0,0,4
56,Translation Factors WP107,0.2697813682280821,2.3659217877094973,3.0996968039866757,"['EEF1B2', 'EIF3I', 'EIF4H', 'EIF3D']",0.9986840967066791,0,0,4
57,Eukaryotic Transcription Initiation WP405,0.2697813682280821,2.3659217877094973,3.0996968039866757,"['GTF2A2', 'TAF13', 'POLR2I', 'POLR2K']",0.9986840967066791,0,0,4
58,GABA receptor Signaling WP4159,0.2697813682280821,2.3659217877094973,3.0996968039866757,"['GABBR1', 'SLC32A1', 'SLC6A1', 'GABRD']",0.9986840967066791,0,0,4
59,Melanoma WP4685,0.2697813682280821,2.3659217877094973,3.0996968039866757,"['CDKN2A', 'KIT', 'BAX', 'GADD45G']",0.9986840967066791,0,0,4
60,Modulators of TCR signaling and T cell activation WP5072,0.27712402604950265,1.972027972027972,2.5306840237776886,"['FIBP', 'NDUFB10', 'ELOB', 'LCP2', 'RNF7']",0.9986840967066791,0,0,5
61,Ciliary landscape WP4352,0.2801830265655604,1.7752100840336134,2.2586214884048275,"['PSMD8', 'VPS4A', 'COPS7A', 'MYL6B', 'WDR34', 'LSM4']",0.9986840967066791,0,0,6
62,Spinal Cord Injury WP2431,0.389614827446378,1.4184873949579833,1.337061466286096,"['TGFB1', 'APEX1', 'OMG', 'AQP4', 'SLIT3', 'GFAP']",0.9986840967066791,0,0,6
63,Cell cycle WP179,0.3994867288850658,1.4772727272727273,1.3555081292395146,"['TGFB1', 'CDKN2A', 'CDC14B', 'ANAPC11', 'GADD45G']",0.9986840967066791,0,0,5
64,Proximal tubule transport WP4917,0.3994867288850658,1.4772727272727273,1.3555081292395146,"['ATP6V1G1', 'ATP1A1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.9986840967066791,0,0,5
65,Ras signaling WP4223,0.3994867288850658,1.4772727272727273,1.3555081292395146,"['GNG4', 'KIT', 'PLD1', 'FGFR2', 'ARF6']",0.9986840967066791,0,0,5
66,22q11.2 copy number variation syndrome WP4657,0.4105097262378351,1.5754189944134078,1.4026832134017229,"['RANBP1', 'MRPL40', 'DGCR6L', 'FGFR2']",0.9986840967066791,0,0,4
67,Apoptosis WP254,0.4105097262378351,1.5754189944134078,1.4026832134017229,"['HRK', 'CDKN2A', 'CYCS', 'BAX']",0.9986840967066791,0,0,4
68,Synaptic Vesicle Pathway WP2267,0.4105097262378351,1.5754189944134078,1.4026832134017229,"['RAB3A', 'SLC32A1', 'PARK7', 'CPLX3']",0.9986840967066791,0,0,4
69,Endometrial cancer WP4155,0.4105097262378351,1.5754189944134078,1.4026832134017229,"['BAX', 'FGF1', 'FGFR2', 'GADD45G']",0.9986840967066791,0,0,4
70,Hippo-Merlin Signaling Dysregulation WP4541,0.4105097262378351,1.5754189944134078,1.4026832134017229,"['PPP1R14A', 'PRKAR1A', 'KIT', 'FGFR2']",0.9986840967066791,0,0,4
71,Non-small cell lung cancer WP4255,0.4105097262378351,1.5754189944134078,1.4026832134017229,"['CDKN2A', 'CYCS', 'BAX', 'GADD45G']",0.9986840967066791,0,0,4
72,Alzheimer's disease WP2059,0.42316952204733704,1.7719665271966527,1.5238600602294519,"['ATP5MD', 'CYCS', 'APOE']",0.9986840967066791,0,0,3
73,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.42316952204733704,1.7719665271966527,1.5238600602294519,"['SFRP1', 'SST', 'DCN']",0.9986840967066791,0,0,3
74,TP53 network WP1742,0.42316952204733704,1.7719665271966527,1.5238600602294519,"['SUMO1', 'CDKN2A', 'BAX']",0.9986840967066791,0,0,3
75,Complement system WP2806,0.42316952204733704,1.7719665271966527,1.5238600602294519,"['RPS19', 'CD59', 'DCN']",0.9986840967066791,0,0,3
76,Zinc homeostasis WP3529,0.42316952204733704,1.7719665271966527,1.5238600602294519,"['SLC39A11', 'SLC39A7', 'SLC39A3']",0.9986840967066791,0,0,3
77,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.42316952204733704,1.7719665271966527,1.5238600602294519,"['LDHA', 'PKM', 'BAX']",0.9986840967066791,0,0,3
78,ACE Inhibitor Pathway WP554,0.4384359313944599,2.362116991643454,1.9476636915740828,"['TGFB1', 'ATP6AP2']",0.9986840967066791,0,0,2
79,BMP Signaling Pathway in Eyelid Development WP3927,0.4384359313944599,2.362116991643454,1.9476636915740828,"['SFRP1', 'FGFR2']",0.9986840967066791,0,0,2
80,Cell migration and invasion through p75NTR WP4561,0.4384359313944599,2.362116991643454,1.9476636915740828,"['EFNA3', 'EFNB3']",0.9986840967066791,0,0,2
81,Type II interferon signaling (IFNG) WP619,0.4384359313944599,2.362116991643454,1.9476636915740828,"['PRKCD', 'HLA-B']",0.9986840967066791,0,0,2
82,Vitamin D-sensitive calcium signaling in depression WP4698,0.4384359313944599,2.362116991643454,1.9476636915740828,"['GPX4', 'PVALB']",0.9986840967066791,0,0,2
83,Cysteine and methionine catabolism WP4504,0.4384359313944599,2.362116991643454,1.9476636915740828,"['GOT1', 'GSS']",0.9986840967066791,0,0,2
84,Glycogen Synthesis and Degradation WP500,0.4384359313944599,2.362116991643454,1.9476636915740828,"['PHKG1', 'PPP2R5B']",0.9986840967066791,0,0,2
85,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.4384359313944599,2.362116991643454,1.9476636915740828,"['FGF1', 'FGFR2']",0.9986840967066791,0,0,2
86,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.4384359313944599,2.362116991643454,1.9476636915740828,"['IFITM3', 'DDIT3']",0.9986840967066791,0,0,2
87,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.4384359313944599,2.362116991643454,1.9476636915740828,"['FGFR2', 'GADD45G']",0.9986840967066791,0,0,2
88,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.4384359313944599,2.362116991643454,1.9476636915740828,"['MAP1LC3A', 'FTL']",0.9986840967066791,0,0,2
89,Pre-implantation embryo WP3527,0.4384359313944599,2.362116991643454,1.9476636915740828,"['DDIT3', 'ATP1A1']",0.9986840967066791,0,0,2
90,15q11.2 copy number variation syndrome WP4940,0.45889088061700617,inf,inf,['TUBGCP4'],0.9986840967066791,0,0,1
91,Selective expression of chemokine receptors during T-cell polarization WP4494,0.45889088061700617,inf,inf,['TGFB1'],0.9986840967066791,0,0,1
92,16p11.2 distal deletion syndrome WP4950,0.45889088061700617,inf,inf,['CD81'],0.9986840967066791,0,0,1
93,Serotonin and anxiety WP3947,0.45889088061700617,inf,inf,['CRH'],0.9986840967066791,0,0,1
94,Serotonin and anxiety-related events WP3944,0.45889088061700617,inf,inf,['CRH'],0.9986840967066791,0,0,1
95,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.45889088061700617,inf,inf,['APOE'],0.9986840967066791,0,0,1
96,Apoptosis Modulation by HSP70 WP384,0.45889088061700617,inf,inf,['CYCS'],0.9986840967066791,0,0,1
97,TCA cycle in senescence WP5050,0.45889088061700617,inf,inf,['GOT1'],0.9986840967066791,0,0,1
98,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.45889088061700617,inf,inf,['TGFB1'],0.9986840967066791,0,0,1
99,Biomarkers for urea cycle disorders WP4583,0.45889088061700617,inf,inf,['GOT1'],0.9986840967066791,0,0,1
100,Thiamine metabolic pathways WP4297,0.45889088061700617,inf,inf,['BCKDK'],0.9986840967066791,0,0,1
101,Cannabinoid receptor signaling WP3869,0.45889088061700617,inf,inf,['PRKAR1A'],0.9986840967066791,0,0,1
102,Canonical and non-canonical TGF-B signaling WP3874,0.45889088061700617,inf,inf,['TGFB1'],0.9986840967066791,0,0,1
103,Urea cycle and associated pathways WP4595,0.45889088061700617,inf,inf,['GOT1'],0.9986840967066791,0,0,1
104,Vitamin D in inflammatory diseases WP4482,0.45889088061700617,inf,inf,['DUSP1'],0.9986840967066791,0,0,1
105,Wnt Signaling Pathway WP363,0.45889088061700617,inf,inf,['ROR2'],0.9986840967066791,0,0,1
106,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.45889088061700617,inf,inf,['RPH3AL'],0.9986840967066791,0,0,1
107,Disruption of postsynaptic signaling by CNV WP4875,0.45889088061700617,inf,inf,['SHANK1'],0.9986840967066791,0,0,1
108,Ebstein-Barr virus LMP1 signaling WP262,0.45889088061700617,inf,inf,['HSP90AA1'],0.9986840967066791,0,0,1
109,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.45889088061700617,inf,inf,['H3F3B'],0.9986840967066791,0,0,1
110,EV release from cardiac cells and their functional effects WP3297,0.45889088061700617,inf,inf,['RGS16'],0.9986840967066791,0,0,1
111,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.45889088061700617,inf,inf,['GSS'],0.9986840967066791,0,0,1
112,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.45889088061700617,inf,inf,['GABBR1'],0.9986840967066791,0,0,1
113,Heart Development WP1591,0.45889088061700617,inf,inf,['VEGFB'],0.9986840967066791,0,0,1
114,HIF1A and PPARG regulation of glycolysis WP2456,0.45889088061700617,inf,inf,['LDHA'],0.9986840967066791,0,0,1
115,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.45889088061700617,inf,inf,['ELOB'],0.9986840967066791,0,0,1
116,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.45889088061700617,inf,inf,['MAP1LC3A'],0.9986840967066791,0,0,1
117,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.45889088061700617,inf,inf,['TGFB1'],0.9986840967066791,0,0,1
118,Intraflagellar transport proteins binding to dynein WP4532,0.45889088061700617,inf,inf,['WDR34'],0.9986840967066791,0,0,1
119,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.45889088061700617,inf,inf,['GABRD'],0.9986840967066791,0,0,1
120,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.45889088061700617,inf,inf,['VEGFB'],0.9986840967066791,0,0,1
121,Mitochondrial fatty acid synthesis pathway WP4317,0.45889088061700617,inf,inf,['HSD17B12'],0.9986840967066791,0,0,1
122,Mitochondrial Gene Expression WP391,0.45889088061700617,inf,inf,['PPRC1'],0.9986840967066791,0,0,1
123,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.45889088061700617,inf,inf,['GOT1'],0.9986840967066791,0,0,1
124,NAD+ metabolism WP3644,0.45889088061700617,inf,inf,['NMNAT1'],0.9986840967066791,0,0,1
125,Nanoparticle triggered autophagic cell death WP2509,0.45889088061700617,inf,inf,['MAP1LC3A'],0.9986840967066791,0,0,1
126,Nanoparticle triggered regulated necrosis WP2513,0.45889088061700617,inf,inf,['FTL'],0.9986840967066791,0,0,1
127,Non-homologous end joining WP438,0.45889088061700617,inf,inf,['DCLRE1C'],0.9986840967066791,0,0,1
128,Oxidative Stress WP408,0.45889088061700617,inf,inf,['TXN2'],0.9986840967066791,0,0,1
129,Peroxiredoxin 2 induced ovarian failure WP4873,0.45889088061700617,inf,inf,['BAX'],0.9986840967066791,0,0,1
130,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.45889088061700617,inf,inf,['LDHA'],0.9986840967066791,0,0,1
131,Platelet-mediated interactions with vascular and circulating cells WP4462,0.45889088061700617,inf,inf,['TGFB1'],0.9986840967066791,0,0,1
132,Selenium Micronutrient Network WP15,0.4982974179161764,1.180672268907563,0.8224068978730763,"['SELENOM', 'GPX4', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH']",0.9986840967066791,0,0,6
133,Integrated breast cancer pathway WP1984,0.4982974179161764,1.180672268907563,0.8224068978730763,"['DCAKD', 'ODC1', 'BAX', 'PHB', 'FAU', 'JAKMIP1']",0.9986840967066791,0,0,6
134,Pyrimidine metabolism WP4022,0.4982974179161764,1.180672268907563,0.8224068978730763,"['POLE4', 'POLE2', 'NME2', 'POLR2I', 'POLR2K', 'POLR2L']",0.9986840967066791,0,0,6
135,Ectoderm Differentiation WP2858,0.5187903635280046,1.1804195804195805,0.7746567253958548,"['PIM1', 'ROR2', 'NR2F2', 'JAKMIP1', 'FGFR2']",0.9986840967066791,0,0,5
136,Hepatitis B infection WP4666,0.5187903635280046,1.1804195804195805,0.7746567253958548,"['TGFB1', 'ATP6AP1', 'VDAC3', 'CYCS', 'BAX']",0.9986840967066791,0,0,5
137,T-cell receptor (TCR) signaling pathway WP69,0.5438953393059218,1.1801675977653632,0.7187202278865451,"['TGFB1', 'RIPK2', 'PRKCD', 'LCP2']",0.9986840967066791,0,0,4
138,Cardiac Progenitor Differentiation WP2406,0.5438953393059218,1.1801675977653632,0.7187202278865451,"['MESP1', 'TGFB1', 'KIT', 'ROR2']",0.9986840967066791,0,0,4
139,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5438953393059218,1.1801675977653632,0.7187202278865451,"['TGFB1', 'CYCS', 'BAX', 'GADD45G']",0.9986840967066791,0,0,4
140,Pathways Regulating Hippo Signaling WP4540,0.5438953393059218,1.1801675977653632,0.7187202278865451,"['PRKAR1A', 'PRKCD', 'KIT', 'FGFR2']",0.9986840967066791,0,0,4
141,MAPK Signaling Pathway WP382,0.5759362020789242,1.0320827489481066,0.5694603104366156,"['DUSP4', 'TGFB1', 'DUSP1', 'DDIT3', 'PRKCD', 'FGF1', 'FGFR2']",0.9986840967066791,0,0,7
142,16p11.2 proximal deletion syndrome WP4949,0.5765575541485521,1.1799163179916319,0.6497564483965921,"['ASPHD1', 'SEZ6L2', 'CCT7']",0.9986840967066791,0,0,3
143,Differentiation Pathway WP2848,0.5765575541485521,1.1799163179916319,0.6497564483965921,"['TGFB1', 'KIT', 'FGF1']",0.9986840967066791,0,0,3
144,DNA damage response WP707,0.5765575541485521,1.1799163179916319,0.6497564483965921,"['CYCS', 'BAX', 'GADD45G']",0.9986840967066791,0,0,3
145,One-carbon metabolism and related pathways WP3940,0.5765575541485521,1.1799163179916319,0.6497564483965921,"['GPX4', 'GSS', 'PLD1']",0.9986840967066791,0,0,3
146,IL-18 signaling pathway WP4754,0.6173240727819126,0.9573019801980198,0.4617652873681583,"['TOMM40', 'USP5', 'CD81', 'RGS16', 'PRKCD', 'COX17', 'NDUFC1', 'PLD1', 'TMSB4X', 'RFX5', 'CYCS', 'BAX', 'ARF6']",0.9986840967066791,0,0,13
147,3q29 copy number variation syndrome WP4906,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['TGFB1', 'WDR34']",0.9986840967066791,0,0,2
148,Cardiac Hypertrophic Response WP2795,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['TGFB1', 'FGFR2']",0.9986840967066791,0,0,2
149,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['PRKCD', 'PIM1']",0.9986840967066791,0,0,2
150,Tumor suppressor activity of SMARCB1 WP4204,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['H3F3B', 'CDKN2A']",0.9986840967066791,0,0,2
151,White fat cell differentiation WP4149,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['DDIT3', 'NR2F2']",0.9986840967066791,0,0,2
152,Cytosolic DNA-sensing pathway WP4655,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['POLR2K', 'POLR2L']",0.9986840967066791,0,0,2
153,DNA Mismatch Repair WP531,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['POLE4', 'POLE2']",0.9986840967066791,0,0,2
154,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['TGFB1', 'BANF1']",0.9986840967066791,0,0,2
155,Methionine De Novo and Salvage Pathway WP3580,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['ODC1', 'SRM']",0.9986840967066791,0,0,2
156,Neovascularisation processes WP4331,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['TGFB1', 'KIT']",0.9986840967066791,0,0,2
157,Nucleotide Excision Repair WP4753,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['POLE4', 'POLE2']",0.9986840967066791,0,0,2
158,Pregnane X receptor pathway WP2876,0.6236423339933325,1.1796657381615598,0.5570125128518199,"['HSP90AA1', 'PSMC5']",0.9986840967066791,0,0,2
159,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.6594221254654234,0.9430167597765363,0.3926640640847513,"['BEX3', 'RIPK2', 'RNF7', 'APOE']",0.9986840967066791,0,0,4
160,PI3K-Akt signaling pathway WP4172,0.6694989617318677,0.905742145178765,0.3634069942129701,"['EFNA3', 'HSP90AA1', 'GNG4', 'PDGFC', 'KIT', 'VEGFB', 'PPP2R5B', 'SGK1', 'FGF1', 'FGFR2']",0.9986840967066791,0,0,10
161,Small cell lung cancer WP4658,0.7010932930035726,0.8838912133891214,0.31388242295887303,"['CYCS', 'BAX', 'GADD45G']",0.9986840967066791,0,0,3
162,Allograft Rejection WP2328,0.7010932930035726,0.8838912133891214,0.31388242295887303,"['TGFB1', 'COL5A1', 'HLA-B']",0.9986840967066791,0,0,3
163,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7010932930035726,0.8838912133891214,0.31388242295887303,"['PPP1R14A', 'MAP1LC3A', 'DDIT3']",0.9986840967066791,0,0,3
164,MECP2 and Associated Rett Syndrome WP3584,0.7010932930035726,0.8838912133891214,0.31388242295887303,"['DLX5', 'SST', 'SGK1']",0.9986840967066791,0,0,3
165,miRNA regulation of DNA damage response WP1530,0.7010932930035726,0.8838912133891214,0.31388242295887303,"['CYCS', 'BAX', 'GADD45G']",0.9986840967066791,0,0,3
166,Signal transduction through IL1R WP4496,0.7073590659799895,1.1794158553546592,0.4083336650861172,['TGFB1'],0.9986840967066791,0,0,1
167,Splicing factor NOVA regulated synaptic proteins WP4148,0.7073590659799895,1.1794158553546592,0.4083336650861172,['NTNG1'],0.9986840967066791,0,0,1
168,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7073590659799895,1.1794158553546592,0.4083336650861172,['LCP2'],0.9986840967066791,0,0,1
169,Trans-sulfuration and one-carbon metabolism WP2525,0.7073590659799895,1.1794158553546592,0.4083336650861172,['GSS'],0.9986840967066791,0,0,1
170,Trans-sulfuration pathway WP2333,0.7073590659799895,1.1794158553546592,0.4083336650861172,['GOT1'],0.9986840967066791,0,0,1
171,Transcription co-factors SKI and SKIL protein partners WP4533,0.7073590659799895,1.1794158553546592,0.4083336650861172,['MERTK'],0.9986840967066791,0,0,1
172,Transcriptional cascade regulating adipogenesis WP4211,0.7073590659799895,1.1794158553546592,0.4083336650861172,['DDIT3'],0.9986840967066791,0,0,1
173,Tryptophan catabolism leading to NAD+ production WP4210,0.7073590659799895,1.1794158553546592,0.4083336650861172,['NMNAT1'],0.9986840967066791,0,0,1
174,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7073590659799895,1.1794158553546592,0.4083336650861172,['CCK'],0.9986840967066791,0,0,1
175,Composition of Lipid Particles WP3601,0.7073590659799895,1.1794158553546592,0.4083336650861172,['APOE'],0.9986840967066791,0,0,1
176,Cytokines and Inflammatory Response WP530,0.7073590659799895,1.1794158553546592,0.4083336650861172,['TGFB1'],0.9986840967066791,0,0,1
177,Dopaminergic Neurogenesis WP2855,0.7073590659799895,1.1794158553546592,0.4083336650861172,['TGFB1'],0.9986840967066791,0,0,1
178,Energy Metabolism WP1541,0.7073590659799895,1.1794158553546592,0.4083336650861172,['PPRC1'],0.9986840967066791,0,0,1
179,Fatty acid transporters WP5061,0.7073590659799895,1.1794158553546592,0.4083336650861172,['FABP3'],0.9986840967066791,0,0,1
180,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.7073590659799895,1.1794158553546592,0.4083336650861172,['FGFR2'],0.9986840967066791,0,0,1
181,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7073590659799895,1.1794158553546592,0.4083336650861172,['SGK1'],0.9986840967066791,0,0,1
182,Galanin receptor pathway WP4970,0.7073590659799895,1.1794158553546592,0.4083336650861172,['PRKCD'],0.9986840967066791,0,0,1
183,Gastric Cancer Network 2 WP2363,0.7073590659799895,1.1794158553546592,0.4083336650861172,['FANCI'],0.9986840967066791,0,0,1
184,Glycerolipids and Glycerophospholipids WP4722,0.7073590659799895,1.1794158553546592,0.4083336650861172,['PLD1'],0.9986840967066791,0,0,1
185,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7073590659799895,1.1794158553546592,0.4083336650861172,['TGFB1'],0.9986840967066791,0,0,1
186,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7073590659799895,1.1794158553546592,0.4083336650861172,['LDHA'],0.9986840967066791,0,0,1
187,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7073590659799895,1.1794158553546592,0.4083336650861172,['BAX'],0.9986840967066791,0,0,1
188,Joubert Syndrome WP4656,0.7073590659799895,1.1794158553546592,0.4083336650861172,['KAT5'],0.9986840967066791,0,0,1
189,Kit receptor signaling pathway WP304,0.7073590659799895,1.1794158553546592,0.4083336650861172,['KIT'],0.9986840967066791,0,0,1
190,Lipid Metabolism Pathway WP3965,0.7073590659799895,1.1794158553546592,0.4083336650861172,['PRKAR1A'],0.9986840967066791,0,0,1
191,Mammalian disorder of sexual development WP4842,0.7073590659799895,1.1794158553546592,0.4083336650861172,['FGFR2'],0.9986840967066791,0,0,1
192,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.7073590659799895,1.1794158553546592,0.4083336650861172,['BAX'],0.9986840967066791,0,0,1
193,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.7073590659799895,1.1794158553546592,0.4083336650861172,['APOE'],0.9986840967066791,0,0,1
194,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7073590659799895,1.1794158553546592,0.4083336650861172,['BAX'],0.9986840967066791,0,0,1
195,Monoamine Transport WP727,0.7073590659799895,1.1794158553546592,0.4083336650861172,['SLC6A1'],0.9986840967066791,0,0,1
196,MTHFR deficiency WP4288,0.7073590659799895,1.1794158553546592,0.4083336650861172,['CYCS'],0.9986840967066791,0,0,1
197,NAD Biosynthesis II (from tryptophan) WP2485,0.7073590659799895,1.1794158553546592,0.4083336650861172,['NMNAT1'],0.9986840967066791,0,0,1
198,NAD+ biosynthetic pathways WP3645,0.7073590659799895,1.1794158553546592,0.4083336650861172,['NMNAT1'],0.9986840967066791,0,0,1
199,Overview of nanoparticle effects WP3287,0.7073590659799895,1.1794158553546592,0.4083336650861172,['BAX'],0.9986840967066791,0,0,1
200,Oxidation by Cytochrome P450 WP43,0.7073590659799895,1.1794158553546592,0.4083336650861172,['CYB5R1'],0.9986840967066791,0,0,1
201,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7073590659799895,1.1794158553546592,0.4083336650861172,['TRPC3'],0.9986840967066791,0,0,1
202,Purinergic signaling WP4900,0.7073590659799895,1.1794158553546592,0.4083336650861172,['P2RY14'],0.9986840967066791,0,0,1
203,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7073590659799895,1.1794158553546592,0.4083336650861172,['ANAPC11'],0.9986840967066791,0,0,1
204,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7073590659799895,1.1794158553546592,0.4083336650861172,['TGFB1'],0.9986840967066791,0,0,1
205,Apoptosis Modulation and Signaling WP1772,0.7179644269535241,0.8411588411588412,0.2787055797989709,"['HRK', 'ENDOG', 'CDKN2A', 'CYCS', 'BAX']",0.9986840967066791,0,0,5
206,Gastrin signaling pathway WP4659,0.7531765220976113,0.7849162011173184,0.2224889347768225,"['KAT5', 'CDKN2A', 'PRKCD', 'KIT']",0.9986840967066791,0,0,4
207,AGE/RAGE pathway WP2324,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['PRKCD', 'CYCS']",0.9986840967066791,0,0,2
208,Aryl Hydrocarbon Receptor Netpath WP2586,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['HSP90AA1', 'AIP']",0.9986840967066791,0,0,2
209,ATM Signaling Network in Development and Disease  WP3878,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['DCLRE1C', 'KAT5']",0.9986840967066791,0,0,2
210,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['APEX1', 'PLD1']",0.9986840967066791,0,0,2
211,TNF-alpha signaling pathway WP231,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['HSP90AA1', 'BAX']",0.9986840967066791,0,0,2
212,Copper homeostasis WP3286,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['COX17', 'ATOX1']",0.9986840967066791,0,0,2
213,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['RIPK2', 'CYCS']",0.9986840967066791,0,0,2
214,G1 to S cell cycle control WP45,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['CDKN2A', 'POLE2']",0.9986840967066791,0,0,2
215,IL-6 signaling pathway WP364,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['PRKCD', 'VIP']",0.9986840967066791,0,0,2
216,Mesodermal commitment pathway WP2857,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['PRKAR1A', 'RPL38']",0.9986840967066791,0,0,2
217,Parkinson's disease pathway WP2371,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['CYCS', 'PARK7']",0.9986840967066791,0,0,2
218,Peptide GPCRs WP24,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['MC1R', 'ACKR1']",0.9986840967066791,0,0,2
219,Retinoblastoma gene in cancer WP2446,0.7572906914835776,0.7855153203342619,0.21837961752747073,"['H2AFZ', 'POLE2']",0.9986840967066791,0,0,2
220,Myometrial relaxation and contraction pathways WP289,0.762500766889598,0.7843137254901961,0.21266805077978534,"['IGFBP5', 'PRKAR1A', 'GNG4', 'RGS16', 'PRKCD', 'CRH']",0.9986840967066791,0,0,6
221,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7681410584665226,0.8077397743300423,0.21306712657993107,"['EFNA3', 'HSP90AA1', 'COL5A1', 'PIK3IP1', 'GNG4', 'PDGFC', 'KIT', 'VEGFB', 'PPP2R5B', 'FGF1', 'FGFR2']",0.9986840967066791,0,0,11
222,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7954119279787762,0.7062761506276151,0.161663185523631,"['PDGFC', 'BAX', 'FGFR2']",0.9986840967066791,0,0,3
223,Exercise-induced Circadian Regulation WP410,0.7954119279787762,0.7062761506276151,0.161663185523631,"['DNAJA1', 'DAZAP2', 'SUMO1']",0.9986840967066791,0,0,3
224,Senescence and Autophagy in Cancer WP615,0.7978148858126154,0.747928088741553,0.1689410102486023,"['GABARAPL1', 'TGFB1', 'MAP1LC3A', 'IGFBP5', 'CDKN2A', 'GABARAP', 'SLC39A3']",0.9986840967066791,0,0,7
225,NRF2 pathway WP2884,0.7978148858126154,0.747928088741553,0.1689410102486023,"['HSP90AA1', 'TGFB1', 'SLC39A11', 'SLC39A7', 'SLC6A1', 'SLC39A3', 'FTL']",0.9986840967066791,0,0,7
226,Androgen receptor signaling pathway WP138,0.8255992411911921,0.6719872306464485,0.12878353266159198,"['SUMO1', 'KAT5', 'PARK7', 'FKBP4']",0.9986840967066791,0,0,4
227,EGF/EGFR signaling pathway WP437,0.8255992411911921,0.6719872306464485,0.12878353266159198,"['NDUFA13', 'PRKCD', 'PLD1', 'ARF6']",0.9986840967066791,0,0,4
228,Sleep regulation WP3591,0.8418203553171684,0.5890125173852573,0.10142126562702815,['CRH'],0.9986840967066791,0,0,1
229,Airway smooth muscle cell contraction WP4962,0.8418203553171684,0.5890125173852573,0.10142126562702815,['PPP1R14A'],0.9986840967066791,0,0,1
230,Alanine and aspartate metabolism WP106,0.8418203553171684,0.5890125173852573,0.10142126562702815,['GOT1'],0.9986840967066791,0,0,1
231,Alpha 6 Beta 4 signaling pathway WP244,0.8418203553171684,0.5890125173852573,0.10142126562702815,['PRKCD'],0.9986840967066791,0,0,1
232,Angiogenesis WP1539,0.8418203553171684,0.5890125173852573,0.10142126562702815,['FGFR2'],0.9986840967066791,0,0,1
233,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8418203553171684,0.5890125173852573,0.10142126562702815,['TGFB1'],0.9986840967066791,0,0,1
234,Vitamin B12 metabolism WP1533,0.8418203553171684,0.5890125173852573,0.10142126562702815,['APOE'],0.9986840967066791,0,0,1
235,Constitutive Androstane Receptor Pathway WP2875,0.8418203553171684,0.5890125173852573,0.10142126562702815,['HSP90AA1'],0.9986840967066791,0,0,1
236,Development and heterogeneity of the ILC family WP3893,0.8418203553171684,0.5890125173852573,0.10142126562702815,['NFIL3'],0.9986840967066791,0,0,1
237,Genes related to primary cilium development (based on CRISPR) WP4536,0.8418203553171684,0.5890125173852573,0.10142126562702815,['WDR34'],0.9986840967066791,0,0,1
238,Genes targeted by miRNAs in adipocytes WP1992,0.8418203553171684,0.5890125173852573,0.10142126562702815,['TMSB4X'],0.9986840967066791,0,0,1
239,IL-3 signaling pathway WP286,0.8418203553171684,0.5890125173852573,0.10142126562702815,['TGFB1'],0.9986840967066791,0,0,1
240,IL-4 signaling pathway WP395,0.8418203553171684,0.5890125173852573,0.10142126562702815,['NFIL3'],0.9986840967066791,0,0,1
241,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8418203553171684,0.5890125173852573,0.10142126562702815,['PRKCD'],0.9986840967066791,0,0,1
242,Matrix Metalloproteinases WP129,0.8418203553171684,0.5890125173852573,0.10142126562702815,['MMP16'],0.9986840967066791,0,0,1
243,Melatonin metabolism and effects WP3298,0.8418203553171684,0.5890125173852573,0.10142126562702815,['APOE'],0.9986840967066791,0,0,1
244,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8418203553171684,0.5890125173852573,0.10142126562702815,['B3GALT2'],0.9986840967066791,0,0,1
245,Neural Crest Cell Migration during Development WP4564,0.8418203553171684,0.5890125173852573,0.10142126562702815,['EPHB3'],0.9986840967066791,0,0,1
246,Neural Crest Cell Migration in Cancer WP4565,0.8418203553171684,0.5890125173852573,0.10142126562702815,['EPHB3'],0.9986840967066791,0,0,1
247,Nuclear receptors WP170,0.8418203553171684,0.5890125173852573,0.10142126562702815,['NR2F2'],0.9986840967066791,0,0,1
248,Ovarian infertility WP34,0.8418203553171684,0.5890125173852573,0.10142126562702815,['INHA'],0.9986840967066791,0,0,1
249,Oxidative Damage WP3941,0.8418203553171684,0.5890125173852573,0.10142126562702815,['CYCS'],0.9986840967066791,0,0,1
250,Prion disease pathway WP3995,0.8418203553171684,0.5890125173852573,0.10142126562702815,['RFX5'],0.9986840967066791,0,0,1
251,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8418203553171684,0.5890125173852573,0.10142126562702815,['BAX'],0.9986840967066791,0,0,1
252,B Cell Receptor Signaling Pathway WP23,0.8476570826022976,0.5884401114206128,0.09725685713839023,"['CD81', 'PRKCD']",0.9986840967066791,0,0,2
253,Chemokine signaling pathway WP3929,0.8476570826022976,0.5884401114206128,0.09725685713839023,"['GNG4', 'PRKCD']",0.9986840967066791,0,0,2
254,Genotoxicity pathway WP4286,0.8476570826022976,0.5884401114206128,0.09725685713839023,"['RPS27', 'PHLDA3']",0.9986840967066791,0,0,2
255,Head and Neck Squamous Cell Carcinoma WP4674,0.8476570826022976,0.5884401114206128,0.09725685713839023,"['CDKN2A', 'FGFR2']",0.9986840967066791,0,0,2
256,Imatinib and Chronic Myeloid Leukemia WP3640,0.8476570826022976,0.5884401114206128,0.09725685713839023,"['KIT', 'PIM1']",0.9986840967066791,0,0,2
257,Lung fibrosis WP3624,0.8476570826022976,0.5884401114206128,0.09725685713839023,"['TGFB1', 'FGF1']",0.9986840967066791,0,0,2
258,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8476570826022976,0.5884401114206128,0.09725685713839023,"['TGFB1', 'FGFR2']",0.9986840967066791,0,0,2
259,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8476570826022976,0.5884401114206128,0.09725685713839023,"['IFI27L2', 'PRKCD']",0.9986840967066791,0,0,2
260,Photodynamic therapy-induced unfolded protein response WP3613,0.8476570826022976,0.5884401114206128,0.09725685713839023,"['DDIT3', 'DNAJB9']",0.9986840967066791,0,0,2
261,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8476570826022976,0.5884401114206128,0.09725685713839023,"['BAX', 'ANGPTL1']",0.9986840967066791,0,0,2
262,Calcium Regulation in the Cardiac Cell WP536,0.8501730799303584,0.6526806526806527,0.10594007342201806,"['PRKAR1A', 'GNG4', 'RGS16', 'PRKCD', 'ATP1B2']",0.9986840967066791,0,0,5
263,TGF-beta Signaling Pathway WP366,0.8634066910231987,0.5878661087866108,0.08633956987797362,"['TGFB1', 'PARD6A', 'SUMO1']",0.9986840967066791,0,0,3
264,Endoderm differentiation WP2853,0.8634066910231987,0.5878661087866108,0.08633956987797362,"['DUSP4', 'SFRP1', 'TGFB1']",0.9986840967066791,0,0,3
265,G Protein Signaling Pathways WP35,0.8634066910231987,0.5878661087866108,0.08633956987797362,"['PRKAR1A', 'GNG4', 'PRKCD']",0.9986840967066791,0,0,3
266,Glioblastoma signaling pathways WP2261,0.8634066910231987,0.5878661087866108,0.08633956987797362,"['CDKN2A', 'PRKCD', 'FGFR2']",0.9986840967066791,0,0,3
267,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.879416531465848,0.5872905027932961,0.07546484682121475,"['PRKAR1A', 'SST', 'ATP1A3', 'AQP4']",0.9986840967066791,0,0,4
268,Wnt signaling WP428,0.9062824287031934,0.4701949860724234,0.046269203792740604,"['SFRP1', 'ROR2']",0.9986840967066791,0,0,2
269,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9062824287031934,0.4701949860724234,0.046269203792740604,"['SFRP1', 'ROR2']",0.9986840967066791,0,0,2
270,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9062824287031934,0.4701949860724234,0.046269203792740604,"['SFRP1', 'ROR2']",0.9986840967066791,0,0,2
271,DNA damage response (only ATM dependent) WP710,0.9106480567146046,0.5032875074716079,0.04710709804447248,"['TGFB1', 'CDKN2A', 'BAX']",0.9986840967066791,0,0,3
272,Ebola Virus Pathway on Host WP4217,0.9106480567146046,0.5032875074716079,0.04710709804447248,"['VPS4A', 'HLA-B', 'MERTK']",0.9986840967066791,0,0,3
273,Osteoblast differentiation WP4787,0.9106480567146046,0.5032875074716079,0.04710709804447248,"['PRKCD', 'FGF1', 'FGFR2']",0.9986840967066791,0,0,3
274,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.9145461168213255,0.39221140472878996,0.035035218747046175,['TGFB1'],0.9986840967066791,0,0,1
275,Target Of Rapamycin (TOR) Signaling WP1471,0.9145461168213255,0.39221140472878996,0.035035218747046175,['RRAGA'],0.9986840967066791,0,0,1
276,BDNF-TrkB Signaling WP3676,0.9145461168213255,0.39221140472878996,0.035035218747046175,['TRPC3'],0.9986840967066791,0,0,1
277,Bladder cancer WP2828,0.9145461168213255,0.39221140472878996,0.035035218747046175,['CDKN2A'],0.9986840967066791,0,0,1
278,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9145461168213255,0.39221140472878996,0.035035218747046175,['TGFB1'],0.9986840967066791,0,0,1
279,Unfolded protein response WP4925,0.9145461168213255,0.39221140472878996,0.035035218747046175,['DDIT3'],0.9986840967066791,0,0,1
280,DNA Replication WP466,0.9145461168213255,0.39221140472878996,0.035035218747046175,['POLE2'],0.9986840967066791,0,0,1
281,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.9145461168213255,0.39221140472878996,0.035035218747046175,['CD81'],0.9986840967066791,0,0,1
282,Genes controlling nephrogenesis WP4823,0.9145461168213255,0.39221140472878996,0.035035218747046175,['FGFR2'],0.9986840967066791,0,0,1
283,Integrated Cancer Pathway WP1971,0.9145461168213255,0.39221140472878996,0.035035218747046175,['BAX'],0.9986840967066791,0,0,1
284,Interleukin-11 Signaling Pathway WP2332,0.9145461168213255,0.39221140472878996,0.035035218747046175,['TGFB1'],0.9986840967066791,0,0,1
285,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.9145461168213255,0.39221140472878996,0.035035218747046175,['RAB3A'],0.9986840967066791,0,0,1
286,Male infertility WP4673,0.9145461168213255,0.39221140472878996,0.035035218747046175,['TEX15'],0.9986840967066791,0,0,1
287,miR-509-3p alteration of YAP1/ECM axis WP3967,0.9145461168213255,0.39221140472878996,0.035035218747046175,['COL5A1'],0.9986840967066791,0,0,1
288,NRF2-ARE regulation WP4357,0.9145461168213255,0.39221140472878996,0.035035218747046175,['AIMP2'],0.9986840967066791,0,0,1
289,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.9145461168213255,0.39221140472878996,0.035035218747046175,['OMG'],0.9986840967066791,0,0,1
290,Phytochemical activity on NRF2 transcriptional activation WP3,0.9145461168213255,0.39221140472878996,0.035035218747046175,['AIMP2'],0.9986840967066791,0,0,1
291,Regulation of toll-like receptor signaling pathway WP1449,0.9145461168213255,0.39221140472878996,0.035035218747046175,['PELI3'],0.9986840967066791,0,0,1
292,Breast cancer pathway WP4262,0.9181750782881278,0.521415270018622,0.04451175614112655,"['KIT', 'BAX', 'FGF1', 'GADD45G']",0.9986840967066791,0,0,4
293,Regulation of Actin Cytoskeleton WP51,0.9425412333961956,0.4398535564853556,0.026028603243845257,"['TMSB4X', 'FGF1', 'FGFR2']",0.9986840967066791,0,0,3
294,Development of ureteric collection system WP5053,0.943239103307326,0.39136490250696376,0.022869592993716995,"['GDF11', 'FGFR2']",0.9986840967066791,0,0,2
295,Metapathway biotransformation Phase I and II WP702,0.943239103307326,0.39136490250696376,0.022869592993716995,"['GPX4', 'GSS']",0.9986840967066791,0,0,2
296,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.943239103307326,0.39136490250696376,0.022869592993716995,"['PSMD8', 'PSMC5']",0.9986840967066791,0,0,2
297,Vitamin D Receptor Pathway WP2877,0.9453757675324429,0.46871508379888266,0.026329035342967235,"['SFRP1', 'TGFB1', 'IGFBP5', 'CDKN2A']",0.9986840967066791,0,0,4
298,Insulin Signaling WP481,0.9453757675324429,0.46871508379888266,0.026329035342967235,"['PRKCD', 'SGK1', 'PFKM', 'ARF6']",0.9986840967066791,0,0,4
299,Statin inhibition of cholesterol production WP430,0.9538597558952485,0.2938108484005563,0.01387922041197651,['APOE'],0.9986840967066791,0,0,1
300,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9538597558952485,0.2938108484005563,0.01387922041197651,['TMSB4X'],0.9986840967066791,0,0,1
301,DNA IR-damage and cellular response via ATR WP4016,0.9538597558952485,0.2938108484005563,0.01387922041197651,['FANCI'],0.9986840967066791,0,0,1
302,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9538597558952485,0.2938108484005563,0.01387922041197651,['TGFB1'],0.9986840967066791,0,0,1
303,Folate Metabolism WP176,0.9538597558952485,0.2938108484005563,0.01387922041197651,['GPX4'],0.9986840967066791,0,0,1
304,Leptin signaling pathway WP2034,0.9538597558952485,0.2938108484005563,0.01387922041197651,['BAX'],0.9986840967066791,0,0,1
305,MET in type 1 papillary renal cell carcinoma WP4205,0.9538597558952485,0.2938108484005563,0.01387922041197651,['RPL11'],0.9986840967066791,0,0,1
306,miRNA targets in ECM and membrane receptors WP2911,0.9538597558952485,0.2938108484005563,0.01387922041197651,['COL5A1'],0.9986840967066791,0,0,1
307,p38 MAPK Signaling Pathway WP400,0.9538597558952485,0.2938108484005563,0.01387922041197651,['DDIT3'],0.9986840967066791,0,0,1
308,PPAR signaling pathway WP3942,0.9538597558952485,0.2938108484005563,0.01387922041197651,['FABP3'],0.9986840967066791,0,0,1
309,Regulation of Microtubule Cytoskeleton WP2038,0.9538597558952485,0.2938108484005563,0.01387922041197651,['PARD6A'],0.9986840967066791,0,0,1
310,Nuclear Receptors Meta-Pathway WP2882,0.9590122775225937,0.5553319919517102,0.023241422304662352,"['PSMC5', 'HSP90AA1', 'TGFB1', 'SLC39A11', 'AIP', 'BAX', 'SLC39A7', 'SLC6A1', 'SLC39A3', 'FTL']",0.9986840967066791,0,0,10
311,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9751001001664091,0.23477051460361614,0.005919772900083821,['TGFB1'],0.9986840967066791,0,0,1
312,Glucocorticoid Receptor Pathway WP2880,0.9751001001664091,0.23477051460361614,0.005919772900083821,['HSP90AA1'],0.9986840967066791,0,0,1
313,"GPCRs, Other WP117",0.9751001001664091,0.23477051460361614,0.005919772900083821,['ACKR1'],0.9986840967066791,0,0,1
314,p53 transcriptional gene network WP4963,0.9751001001664091,0.23477051460361614,0.005919772900083821,['BAX'],0.9986840967066791,0,0,1
315,Phosphodiesterases in neuronal function WP4222,0.9751001001664091,0.23477051460361614,0.005919772900083821,['PDE3A'],0.9986840967066791,0,0,1
316,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9751001001664091,0.23477051460361614,0.005919772900083821,['TGFB1'],0.9986840967066791,0,0,1
317,Circadian rhythm related genes WP3594,0.977204847954214,0.35104602510460253,0.008094762760958225,"['NFIL3', 'CRH', 'RPS27A']",0.9986840967066791,0,0,3
318,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9798981250227935,0.2928272980501393,0.005946346365442886,"['RAB3A', 'PRKCD']",0.9986840967066791,0,0,2
319,ESC Pluripotency Pathways WP3931,0.9798981250227935,0.2928272980501393,0.005946346365442886,"['FGF1', 'FGFR2']",0.9986840967066791,0,0,2
320,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9865695461702065,0.19541029207232266,0.0026422320790232294,['TGFB1'],0.9986840967066791,0,0,1
321,TGF-beta Receptor Signaling WP560,0.9865695461702065,0.19541029207232266,0.0026422320790232294,['TGFB1'],0.9986840967066791,0,0,1
322,Monoamine GPCRs WP58,0.9865695461702065,0.19541029207232266,0.0026422320790232294,['HTR5A'],0.9986840967066791,0,0,1
323,"GPCRs, Class A Rhodopsin-like WP455",0.9904595581969178,0.3332003192338388,0.0031941393485304097,"['MC1R', 'P2RY14', 'HTR5A', 'MCHR1']",0.9986840967066791,0,0,4
324,Adipogenesis WP236,0.9913430494667329,0.2918410041841004,0.002537452352500919,"['WWTR1', 'TGFB1', 'DDIT3']",0.9986840967066791,0,0,3
325,Wnt signaling pathway and pluripotency WP399,0.9927594646207856,0.16729584740711306,0.0012157180572698587,['PRKCD'],0.9986840967066791,0,0,1
326,Oncostatin M Signaling Pathway WP2374,0.9960982430093056,0.14621001390820584,0.0005715917765445278,['PRKCD'],0.9986840967066791,0,0,1
327,Ciliopathies WP4803,0.9978981427094938,0.12980992118683357,0.00027312906904746327,['WDR34'],0.9986840967066791,0,0,1
328,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9978981427094938,0.12980992118683357,0.00027312906904746327,['TGFB1'],0.9986840967066791,0,0,1
329,Endochondral Ossification WP474,0.9978981427094938,0.12980992118683357,0.00027312906904746327,['TGFB1'],0.9986840967066791,0,0,1
330,Focal Adhesion WP306,0.9986840967066791,0.17913006213841867,0.00023587306583171039,"['PDGFC', 'VEGFB']",0.9986840967066791,0,0,2
